Epithelial-Mesenchymal Transition in Acute Leukemias

Area of Science:

• Oncology
• Cell Biology
• Hematology

Background:

• Epithelial-mesenchymal transition (EMT) is a cellular process crucial for development, enabling phenotypic flexibility.
• EMT is implicated in advanced solid tumors, promoting malignancy and treatment resistance.
• While traditionally studied in solid tumors, EMT's role in hematological malignancies is increasingly recognized.

Purpose of the Study:

• To explore the role of EMT in the pathogenesis and progression of acute leukemias.
• To investigate EMT's contribution to chemotherapy resistance in acute leukemias.
• To assess the prognostic value of EMT markers and the therapeutic potential of targeting EMT in acute leukemias.

Main Methods:

• Literature review and analysis of existing studies on EMT in acute leukemias.
• Examination of evidence linking EMT inducers and markers to disease progression and patient prognosis.
• Evaluation of preclinical and clinical data on targeting EMT in hematological malignancies.

Main Results:

• EMT promotes aggressive phenotypes and chemotherapy resistance in acute leukemias.
• EMT is increasingly implicated in the pathogenesis of hematological malignancies.
• Levels and activities of EMT markers correlate with prognosis in acute leukemias.

Conclusions:

• EMT plays a significant role in acute leukemia progression and treatment failure.
• Targeting EMT, alongside conventional therapies, shows promise for improving acute leukemia treatment success.
• EMT markers can serve as predictive indicators for patient prognosis in acute leukemias.